Filing Details
- Accession Number:
- 0001062993-25-010155
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-23 09:04:08
- Reporting Period:
- 2025-05-21
- Filing Date:
- 2025-05-23
- Accepted Time:
- 2025-05-23 09:04:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1533040 | Phio Pharmaceuticals Corp. | PHIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1304395 | J Robert Bitterman | C/O Phio Pharmaceuticals Corp. 11 Apex Dr., Suite 300A, Pmb 2006 Marlborough MA 01752 | Chairman, Pres & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2025-05-21 | 3,000 | $1.77 | 22,449 | No | 4 | P | Direct | |
| Common Stock, $0.0001 Par Value | Acquisiton | 2025-05-22 | 1,200 | $1.78 | 23,649 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Includes shares of common stock underlying unvested restricted stock units.
- The number of reported securities has been adjusted to reflect prior reverse stock splits.
Billionaire Hedge Funds
